Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Equity (Details) - Schedule of stock-based compensation expense

v3.21.1
Shareholders' Equity (Details) - Schedule of stock-based compensation expense - USD ($)
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Schedule of stock-based compensation expense [Abstract]    
Research and development options expense $ 66,632 $ 86,439
Total research and development expenses 66,632 86,439
General and administrative options and warrants expense 407,156 255,568
Stock issued to consultants and employees 850,900 228,626
Total general and administrative expenses 1,258,116 484,194
Total stock-based compensation expense $ 1,324,687 $ 570,633